Thomson Reuters Sharpens AI Focus with Global Print Divestiture and Raised 2026 Guidance

What happened

Thomson Reuters disclosed that its AI push is gaining traction, prompting management to raise its 2026 growth outlook. The company also announced a sale of a majority stake in its Global Print business, a move to further concentrate on higher-value workflow and GenAI offerings. This follows earlier FY2025 results showing 81% recurring revenue and GenAI-enabled products reaching 28% of ACV, with Q4 Legal organic growth of 9%. The divestiture removes a low-growth, lower-margin asset, while the raised outlook suggests management sees stronger-than-expected demand for CoCounsel, Westlaw, and related AI modules. However, the article is a Zacks investment piece and may be promotional; the company's own filings had previously cautioned on AI regulatory uncertainty and competitive pricing pressure.

Implication

The Global Print sale reduces revenue base but improves mix and should support margin expansion toward the company's ~40%+ EBITDA target, though the exact financial impact is not detailed. A raised 2026 outlook indicates management sees AI-driven upsell gaining momentum, but without numbers it is hard to verify whether this reflects only one-time licensing or sustained attach. Key checkpoints remain unchanged: whether GenAI ACV penetration continues to climb above 28% and whether Deep Research converts into paid upgrades without discounting. Competitive threats from LexisNexis+Harvey and Clio+vLex remain, and any increase in reported competitive pricing pressure would undermine the growth narrative. Given the stock's sharp decline, a positive re-rating requires clear evidence of accelerating organic growth and margin expansion, not just strategic divestitures.

Thesis delta

The core thesis that AI monetization must convert to paid attach remains intact, but the Global Print divestiture and raised 2026 outlook slightly strengthen the bull case by improving business mix and signaling management confidence. However, the lack of specific figures in the article means conviction is not materially changed until official filings confirm the magnitude of the guidance increase and the divestiture's financial effect. We maintain a cautious stance: the next quarterly results will be pivotal to validate the improved outlook and demonstrate that competitive pressure is not eroding pricing power.